What To Know About The J&J COVID Vaccine And Guillain-Barre Syndrome

México Noticias Noticias

What To Know About The J&J COVID Vaccine And Guillain-Barre Syndrome
México Últimas Noticias,México Titulares
  • 📰 HuffPostWomen
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 68%

Reports say the FDA may put a warning on the J&J shot after some people developed a rare disorder. Here's why you shouldn't panic.

concluded that there wasn’t enough data to establish a causal relationship between the shot and GBS. But now that 100 people have developed GBS after vaccination, scientists are taking a closer look at the link.

If you’ve experienced GBS in the past, health experts suggest talking to your doctor, and if need be, consider opting for one of the messenger RNA vaccines if you haven’t received your shot already. There are a lot of great options available that can safely keep you protected against COVID-19 and the harms it causes.GBS is a rare reaction in which the immune system goes a bit haywire and attacks the nervous system.

We see it with the flu shot every year, along with the pneumococcal vaccine. “It’s a very, very rare side effect, but amongst neurologists it’s something we see” after flu infection and, less commonly, the flu shot, Stoll said. GBS appears to be even rarer with the J&J COVID vaccine compared to other vaccines like the flu shot, according to Stoll.Recovery, in most cases, is smooth.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

HuffPostWomen /  🏆 27. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

FDA head calls for inquiry into Alzheimer's drug reviewFDA head calls for inquiry into Alzheimer's drug reviewThe acting head of the Food and Drug Administration is calling for a government investigation into highly unusual contacts between her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug
Leer más »

FDA Seeks to Probe Talks Between Staff and Biogen on Alzheimer’s DrugFDA Seeks to Probe Talks Between Staff and Biogen on Alzheimer’s DrugThe FDA’s acting commissioner is taking the highly unusual step of asking for a federal investigation of doctors within her own agency who met with the makers of an Alzheimer’s drug prior to its approval
Leer más »

Declining Vaccine Efficacy—Particularly Among Older Individuals—Prompting Pfizer’s Emergency Booster Request, Former FDA Chief SaysDeclining Vaccine Efficacy—Particularly Among Older Individuals—Prompting Pfizer’s Emergency Booster Request, Former FDA Chief SaysDr. Scott Gottlieb says the United States 'probably missed the window' to provide the follow-up doses before a summer wave of infections.
Leer más »

Vaccines will get full FDA approval, Fauci predictsVaccines will get full FDA approval, Fauci predictsFauci said that the hundreds of millions of people across the world who have been vaccinated serve as evidence that “the effectiveness and the safety of the vaccines are very high”
Leer más »

CDC, FDA looking into risk of nerve complication after Johnson & Johnson Covid-19 vaccineCDC, FDA looking into risk of nerve complication after Johnson & Johnson Covid-19 vaccineJUST IN: Federal health officials are investigating the possibility that Johnson & Johnson's coronavirus vaccine might slightly raise the risk of a rare neurological complication known as Guillain-Barré syndrome, a CDC spokesperson said.
Leer más »

FDA expected to add Guillain-Barre syndrome warning to J&J Covid shotFDA expected to add Guillain-Barre syndrome warning to J&J Covid shotThe FDA is preparing to add a warning to Johnson & Johnson's Covid-19 vaccine after receiving preliminary reports of patients developing the rare neurological condition Guillain-Barré syndrome
Leer más »



Render Time: 2025-03-13 04:31:05